doi.org/10.1126/scitranslmed.aaw8412

Other

Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials

,

Christopher Giuliano

,

..., Jason M. Sheltzer

Science Translational Medicine14.60

Volume: 11, Issue: 509

Published: Sep 11, 2019

Paper Fields

Paper Details

Title

Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials

DOI

doi.org/10.1126/scitranslmed.aaw8412

Published Date

Sep 11, 2019

Journal

Science Translational Medicine

Volume

11

Issue

509

Notes

History